Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2.

Decout A, Silva-Gomes S, Drocourt D, Blattes E, Rivière M, Prandi J, Larrouy-Maumus G, Caminade AM, Hamasur B, Källenius G, Kaur D, Dobos KM, Lucas M, Sutcliffe IC, Besra GS, Appelmelk BJ, Gilleron M, Jackson M, Vercellone A, Tiraby G, Nigou J.

Sci Rep. 2018 Nov 15;8(1):16840. doi: 10.1038/s41598-018-35393-5.

2.

Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.

Källenius G, Correia-Neves M, Buteme H, Hamasur B, Svenson SB.

Tuberculosis (Edinb). 2016 Jan;96:120-30. doi: 10.1016/j.tube.2015.09.005. Epub 2015 Oct 28. Review.

PMID:
26586646
3.

A sensitive urinary lipoarabinomannan test for tuberculosis.

Hamasur B, Bruchfeld J, van Helden P, Källenius G, Svenson S.

PLoS One. 2015 Apr 23;10(4):e0123457. doi: 10.1371/journal.pone.0123457. eCollection 2015.

4.

Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells.

Mazurek J, Ignatowicz L, Kallenius G, Svenson SB, Pawlowski A, Hamasur B.

PLoS One. 2012;7(8):e42515. doi: 10.1371/journal.pone.0042515. Epub 2012 Aug 3.

5.

Mannosylated lipoarabinomannan balances apoptosis and inflammatory state in mycobacteria-infected and uninfected bystander macrophages.

Wojtas B, Fijalkowska B, Wlodarczyk A, Schollenberger A, Niemialtowski M, Hamasur B, Pawlowski A, Krzyzowska M.

Microb Pathog. 2011 Jul-Aug;51(1-2):9-21. doi: 10.1016/j.micpath.2011.03.004. Epub 2011 Apr 1.

PMID:
21440050
6.

Towards new tuberculosis vaccines.

Svenson S, Källenius G, Pawlowski A, Hamasur B.

Hum Vaccin. 2010 Apr;6(4):309-17. Epub 2010 Apr 19. Review.

PMID:
20372087
7.

Mycobacterial glycoconjugates as vaccine candidates against tuberculosis.

Källenius G, Pawlowski A, Hamasur B, Svenson SB.

Trends Microbiol. 2008 Oct;16(10):456-62. doi: 10.1016/j.tim.2008.07.007. Epub 2008 Sep 4.

PMID:
18774297
8.

Gene expression profiling of lipoarabinomannan-treated mouse macrophage cultures infected with Mycobacterium bovis BCG.

Krzyzowska M, Malewski T, Hamasur B, Augustynowicz-Kopeć E, Schollenberger A, Pawłowski A, Niemiałtowski M.

Pol J Microbiol. 2008;57(2):125-33.

9.

Lipoarabinomannan as a regulator of the monocyte apoptotic response to Mycobacterium bovis BCG Danish strain 1331 infection.

Krzyzowska M, Schollenberger A, Pawłowski A, Hamasur B, Winnicka A, Augustynowicz-Kopeć E, Niemiałtowski M.

Pol J Microbiol. 2007;56(2):89-96. Erratum in: Pol J Microbiol. 2007;56(4):following 285.

PMID:
17650678
10.

Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.

Haile M, Hamasur B, Jaxmar T, Gavier-Widen D, Chambers MA, Sanchez B, Schröder U, Källenius G, Svenson SB, Pawlowski A.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):107-14. Epub 2005 Jan 20.

PMID:
15687034
11.

A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Hamasur B, Haile M, Pawlowski A, Schroder U, Kallenius G, Svenson SB.

Clin Exp Immunol. 2004 Oct;138(1):30-8.

12.

Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.

Haile M, Schröder U, Hamasur B, Pawlowski A, Jaxmar T, Källenius G, Svenson SB.

Vaccine. 2004 Mar 29;22(11-12):1498-508.

PMID:
15063575
13.

Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.

Hamasur B, Haile M, Pawlowski A, Schröder U, Williams A, Hatch G, Hall G, Marsh P, Källenius G, Svenson SB.

Vaccine. 2003 Sep 8;21(25-26):4081-93.

PMID:
12922145
14.

Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients.

Tessema TA, Bjune G, Assefa G, Svenson S, Hamasur B, Bjorvatn B.

Scand J Infect Dis. 2002;34(3):167-71.

PMID:
12030387
15.
16.

Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre.

Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B.

Scand J Infect Dis. 2001;33(4):279-84.

PMID:
11345220
17.

Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine.

Hamasur B, Bruchfeld J, Haile M, Pawlowski A, Bjorvatn B, Källenius G, Svenson SB.

J Microbiol Methods. 2001 May;45(1):41-52.

PMID:
11295196
18.
19.

A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan.

Hamasur B, Källenius G, Svenson SB.

FEMS Immunol Med Microbiol. 1999 May;24(1):11-7.

20.

Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis.

Hetland G, Wiker HG, Høgåsen K, Hamasur B, Svenson SB, Harboe M.

Clin Diagn Lab Immunol. 1998 Mar;5(2):211-8.

22.

F0F1-ATPase of plant mitochondria: isolation and polypeptide composition.

Hamasur B, Glaser E.

Biochem Biophys Res Commun. 1990 Aug 16;170(3):1352-8.

PMID:
2143900
23.

Evidence for an endogenous ATPase inhibitor protein in plant mitochondria. Purification and characterization.

Norling B, Tourikas C, Hamasur B, Glaser E.

Eur J Biochem. 1990 Mar 10;188(2):247-52.

24.

Quantitative determination of arsenocholine and acetylarsenocholine in aquatic organisms using pyrolysis and gas chromatography/mass spectrometry.

Christakopoulos A, Hamasur B, Norin H, Nordgren I.

Biomed Environ Mass Spectrom. 1988 Jan 15;15(2):67-74.

PMID:
3349210

Supplemental Content

Loading ...
Support Center